Botulinum toxin: Historical perspective and potential new indications

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Muscle & nerve. Supplement

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/(SICI)1097-4598(1997)6+<129::AID-MUS9>3.0.CO;2-BPMID 9826986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and polymyographic investigation of spasmodic torticollis

  2004cited by this paper
• Treatment of spasmodic torticollis with local injections of botulinum toxin

  2004cited by this paper
• The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.

  1997cited by this paper
• Botulinum toxin treatment of muscle cramps: A clinical and neurophysiological study

  1997cited by this paper
• Uses of botulinum toxin.

  1997cited by this paper
• Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human.

  1997cited by this paper
• Treatment of vaginismus with botulinum toxin injections.

  1997cited by this paper
• Botulinum toxin for palmar hyperhidrosis.

  1997cited by this paper
• The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein

  1997cited by this paper
• Ethnic variation in the clinical expression of idiopathic torsion dystonia

  1997cited by this paper
• Botulinum neurotoxins: mechanism of action and therapeutic applications.

  1996cited by this paper
• Botulinum toxin for refractory vocal tics

  1996cited by this paper
• Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome

  1996cited by this paper
• Botulinum toxin in the therapy of gustatory sweating

  1996cited by this paper
• Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening.

  1996cited by this paper
• A randomized, double‐blind, placebo‐controlled study to evaluate botulinum toxin type A in essential hand tremor

  1996cited by this paper
• Unilateral injection of botulinum toxin in blepharospasm: Single fiber electromyography and blink reflex study

  1996cited by this paper
• Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients.

  1996cited by this paper
• Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution.

  1996cited by this paper
• Cosmetic Denervation of the Muscles of Facial Expression with Botulinum Toxin A Dose‐Response Study

  1996cited by this paper
• Palatal Myoclonus: Treatment with Clostridium botulinum Toxin Injection

  1996cited by this paper
• Frey's syndrome: treatment with botulinum toxin.

  1995cited by this paper
• Response and immunoresistance to botulinum toxin injections

  1995cited by this paper
• Microvascular decompression for hemifacial spasm.

  1995cited by this paper
• Botulinum a toxin for the so‐called apraxia of lid opening

  1995cited by this paper
• Comparison of Therapeutic Efficacies of Type A and F Botulinum Toxins for Blepharospasm

  1995cited by this paper
• Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.

  1995cited by this paper
• Pain and remote weakness in limbs injected with botulinum toxin A for writer's cramp.

  1995cited by this paper
• Pretarsal application of botulinum toxin for treatment of blepharospasm.

  1995cited by this paper
• The gene for hereditary progressive dystonia with marked diurnal fluctuation maps to chromosome 14q

  1995cited by this paper
• Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor.

  1995cited by this paper
• Paroxysmal dyskinesias: Clinical features and classification

  1995cited by this paper
• Motor persistence of orbicularis oculi muscle in eyelid‐opening disorders

  1995cited by this paper
• Botulinum toxin A for spasticity, muscle spasms, and rigidity

  1995cited by this paper
• Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles.

  1995cited by this paper
• Double‐Blind trial of botulinum toxin for treatment of focal hand dystonia

  1995cited by this paper
• Botulinum toxin treatment of essential head tremor

  1995cited by this paper
• Apraxia of lid opening.

  1995cited by this paper
• “Off” painful dystonia in Parkinson's disease treated with botulinum toxin

  1995cited by this paper
• Intrasphincteric botulinum toxin for the treatment of achalasia.

  1995cited by this paper
• Laryngeal botulinum toxin injections for disabling stuttering in adults

  1994cited by this paper
• Botulinum toxin‐A improves the rigidity of progressive supranuclear palsy

  1994cited by this paper
• Botulinum toxin in the treatment of dystonic tics

  1994cited by this paper
• Optimisation of botulinum treatment for cervical and axial dystonias: experience with a Japanese type A toxin.

  1994cited by this paper
• Masticatory muscle spasm in a non‐japanese patient with satoyoshi syndrome successfully treated with botulinum toxin

  1994cited by this paper
• Research opportunities in dystonia

  1994cited by this paper
• Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.

  1994cited by this paper
• Botulinum toxin a injections for the treatment of hand tremors

  1994cited by this paper
• Long‐term botulinum toxin treatment of focal hand dystonia

  1994cited by this paper
• Botulinum toxin in the treatment of writer's cramp

  1993cited by this paper
• Botulinum toxin. From poison to medicine.

  1993cited by this paper
• Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia

  1993cited by this paper
• Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A

  1993cited by this paper
• The use of clostridium botulinum toxin in palatal myclonus. A preliminary report

  1993cited by this paper
• Brachial plexopathy after botulinum toxin administration for cervical dystonia.

  1993cited by this paper
• Significant improvement of stiff‐person syndrome after paraspinal injection of botulinum toxin A

  1993cited by this paper
• Time course of distant effects of local injections of botulinum toxin

  1993cited by this paper
• Strong allelic association between the torsion dystonia gene (DYT1) andloci on chromosome 9q34 in Ashkenazi Jews.

  1992cited by this paper
• Dysphagia after botulinum toxin injections for spasmodic torticollis

  1992cited by this paper
• Therapeutic use of type F botulinum toxin.

  1992cited by this paper
• Botulinum toxin injection for spasmodic torticollis

  1992cited by this paper
• Abductor laryngeal dystonia: A series treated with botulinum toxin

  1992cited by this paper
• Botulinum toxin therapy for limb dystonias

  1992cited by this paper
• Double‐blind controlled study of botulinum toxin in adductor spasmodic dysphonia

  1991cited by this paper
• Torsion dystonia genes in two populations confined to a small region on chromosome 9q32-34.

  1991cited by this paper
• Tremor and idiopathic dystonia

  1991cited by this paper
• Cervical dystonia

  1991cited by this paper
• Laryngeal Dystonia: A Series with Botulinum Toxin Therapy

  1991cited by this paper
• Dopa‐responsive dystonia

  1991cited by this paper
• Therapeutic uses of botulinum toxin.

  1991cited by this paper
• Change in pattern of muscle activity following botulinum toxin injections for torticollis

  1991cited by this paper
• Treatment of idiopathic spasmodic torticollis with botulinum toxin a: A double‐blind study on twenty‐three patients

  1991cited by this paper
• Electromyographic guidance of botulinum toxin treatment in cervical dystonia.

  1991cited by this paper
• Botulinum toxin treatment of tremors

  1991cited by this paper
• Essential tremor

  1991cited by this paper
• Clinical correlates of response to botulinum toxin injections.

  1991cited by this paper
• Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

  1990cited by this paper
• Botulinum a toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread

  1990cited by this paper
• Botulinum toxin injections for cervical dystonia

  1990cited by this paper
• Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.

  1990cited by this paper
• Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study.

  1990cited by this paper
• Botulinum toxin treatment in spasmodic torticollis.

  1990cited by this paper
• Indirect Laryngoscopic Approach for Injection of Botulinum Toxin in Spasmodic Dysphonia

  1990cited by this paper
• Treatment of speech and voice disorders with botulinum toxin.

  1990cited by this paper
• Treatment of blepharospasm with botulinum toxin.

  1989cited by this paper
• Botulinum toxin therapy in hemifacial spasm: Clinical and electrophysiologic studies

  1989cited by this paper
• Treatment of focal dystonias of the hand with botulinum toxin injections.

  1989cited by this paper
• Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia

  1989cited by this paper
• Treatment of anismus in intractable constipation with botulinum A toxin.

  1988cited by this paper
• Blepharospasm: a review of 264 patients.

  1988cited by this paper
• Botulinum A toxin for cranial‐cervical dystonia

  1987cited by this paper
• Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm

  1987cited by this paper
• Double-blind study of botulinum toxin in spasmodic torticollis.

  1986cited by this paper
• Tardive dystonia

  1982cited by this paper
• Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as "Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus" in Zeitschrift für Hygiene und Infektionskrankheiten 26: 1-56, 1897.

  1979cited by this paper
• Pharmacologic weakening of extraocular muscles.

  1973cited by this paper
• The action of botulinum toxin on the neuro‐muscular junction

  1949cited by this paper

• Efficacy and safety of botulinum toxin injection in the management of chronic symptomatic anal fissure: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Botulinum Toxin Therapy: A Comprehensive Review on Clinical and Pharmacological Insights

  2025cites this paper
• The Efficacy of Botulinum Toxin Treatment in Facial Palsy: A Systematic Review

  2025cites this paper
• Psychological Consequences of Cosmetic Botox Therapy

  2025cites this paper
• Are We Missing Something About the Maximum Dosing of Botulinum Toxin Type A1 in Adult and Pediatric Patients with Spasticity?

  2024cites this paper
• Treatment Challenges in Hemifacial Spasm: The Role of Magnetic Resonance Imaging

  2024cites this paper
• Use of botox for sialorrhea and dysphagia in the neonatal population.

  2023cites this paper
• Botulinum Toxin Injections as an Adjunct to Surgical Lip Repositioning For Gummy Smile Treatment

  2022cites this paper
• Intraductal botulinum toxin injection suppressed the inflammation in experimental acute pancreatitis

  2021cites this paper
• Treatment of dystonia

  2021cites this paper
• Mucosal coronally positioned flap technique for management of excessive gingival display

  2020cites this paper
• Focal Management of Spasticity in Cerebral Palsy

  2020cites this paper
• Botulinum toxin

  2020cites this paper
• Overview of Hemifacial Spasm

  2020cites this paper
• Application of Botulinum Neurotoxin in Male Sexual Dysfunction: Where Are We Now?

  2020cites this paper
• Toxina Botulínica Tipo A em Pacientes com Hemiplegia e/ou Hemiparesia Espástica

  2019cites this paper
• Hemifacial Spasm: A Comprehensive Guide

  2019cites this paper
• Rare Complication of Botox Injection: A Case Report

  2019cites this paper
• Chapter 2 Botulinum Toxin Adverse Events

  2019cites this paper
• Botulinum Toxin Treatment in Clinical Medicine: A Disease-Oriented Approach

  2018cites this paper
• Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness?

  2018cites this paper
• Lip Repositioning Surgery: A Newer Paradigm in Periodontal Aesthetics

  2018cites this paper
• Lip repositioning for the treatment of excess gingival display: A systematic review

  2018cites this paper
• Botulinum Toxin Adverse Events

  2018cites this paper
• Botulinum Toxin Treatment in Cerebrovascular Disease

  2018cites this paper
• NEURONAL EXOCYTOSIS INHIBITING PEPTIDES AND COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAD PEPTIDES

  2017cites this paper
• United States Patent Blanes

  2017cites this paper
• Botulinum Toxin A in Blepharospasm and Hemifacial Spasm and Meigeâs Syndrome: An 8 Year of Experience in Northeast India

  2017cites this paper
• Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules.

  2017cites this paper
• Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations

  2017cites this paper
• Tooth Mobility, Periodontal Ligament Space, and the Alveolus During Periodontal Health, Disease, and Disuse

  2016cites this paper
• Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States

  2016cites this paper
• Botulinum Toxin: A Clinical Update on Ophthalmic Uses

  2015cites this paper
• Chapter 28 – Botulinum Toxin*

  2015cites this paper
• Central Action of Botulinum Toxin Type A – Is It Possible?

  2015cites this paper
• Physical therapy for an adult with chronic stroke after botulinum toxin injection for spasticity: a case report.

  2015cites this paper
• Botulinum Neurotoxin Type A in Neurology: Update

  2015cites this paper
• Upper-Limb Therapy in Children Following Injection of Botulinum Neurotoxin A

  2015cites this paper
• Botulinum Toxin Type A as a Therapeutic Agent against Headache and Related Disorders

  2015cites this paper
• Molecular Basis for Persistence of Botulinum Neurotoxin: The Role of Intracellular Protein Degradation Pathways

  2014cites this paper
• Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat Spinal Cord Cells

  2014cites this paper
• Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial

  2014cites this paper
• USE OF BOTULINUM TOXIN IN GUMMY SMILE

  2014cites this paper
• Suppressing SNAP‐25 and reversing glial glutamate transporters relieves neuropathic pain in rats by ameliorating imbalanced neurotransmission

  2013cites this paper
• Botulinum toxins: mechanisms of action, antinociception and clinical applications.

  2013cites this paper
• Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations

  2013cites this paper
• Unizentrische Kohortenstudie zum integrativen Therapiekonzept bei Kindern mit bilateral spastischer Cerebralparese unter besonderer Berücksichtigung der Adhärenz zu der Behandlung mit Botulinumtoxin

  2013influential citation
• The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.

  2012cites this paper
• Application of botulinum toxin to clinical therapy: advances and cautions.

  2012cites this paper
• BOTULINUM TOXIN INJECTION IN CHILDREN WITH CONSTIPATION CAUSED BY INTERNAL ANAL SPHINCTER ACHALASIA

  2012cites this paper
• Factores que influyen en la sexualidad de la población con espina bífida

  2012cites this paper
• Botulinumtoxin bei neurogener Blasenfunktionsstörung

  2012cites this paper
• Effective results with botulinum toxin in cerebral palsy.

  2011cites this paper
• 14 – Botulinum Toxin Injections in Myofascial Pain Disorders

  2011cites this paper
• Voice Characteristics of Adductor Spasmodic Dysphonia before and after Botulinum Toxin-A Injection

  2011cites this paper
• Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial

  2011cites this paper
• Botulinum toxin historical aspects: from food poisoning to pharmaceutical

  2011cites this paper
• Botulinumtoxin-A in der Behandlung neurogener Blasenfunktionsstörungen bei Kindern und Jugendlichen unter besonderer Berücksichtigung von Botulinumtoxin-A Antikörpern bei Therapieversagern

  2010cites this paper
• Botulinum Neurotoxin for Pain Management: Insights from Animal Models

  2010cites this paper
• Indicacions de la toxina botulínica en la primera infància.

  2010cites this paper
• FILLERS AND NEUROTOXINS

  2010cites this paper
• Botulinum toxin: Bioweapon & magic drug

  2010cites this paper
• TheroleoftheinjectionBotulinumToxinAincasesof EssentialBlepharospasmSyndrome,HemifacialSpasmand Meige'sSyndrome

  2010cites this paper
• BOTULINUM TOXIN

  2010cites this paper
• High-frequency ultrasound guidance for neurotoxin injections.

  2010cites this paper
• FOCAL SPASTICITY THERAPY: EFFECTS ON MOTOR FUNCTION, HEALTH RELATED QUALITY OF LIFE, AND CENTRAL NERVOUS SYSTEM PLASTICITY

  2009cites this paper
• Botox to reduce drooling in South African neurologically impaired children : a retrospective study.

  2009influential citation
• Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder.

  2009cites this paper
• Upper-Limb Movement Training in Children Following Injection of Botulinum Toxin A Multiple Sclerosis

  2009cites this paper
• Therapeutic and Cosmetic uses of Botulinum Toxin

  2009cites this paper
• Improved intramuscular blood flow and normalized metabolism in lateral epicondylitis after botulinum toxin treatment

  2009cites this paper
• Botox Treatment for Migraine and Chronic Daily Headache in Adolescents

  2009cites this paper
• Botox: Its Use in Facial Lines and Wrinkles

  2009cites this paper
• Operativno liječenje strabizma nakon primjene botulin toksina kod distiroidne orbitopatije

  2009cites this paper
• Strabismus surgery after application of botulinum toxin in dysthyroid orbitopathy

  2009cites this paper
• Subunit Stoichiometry of the Clostridium botulinum Type A Neurotoxin Complex Determined Using Denaturing Capillary Electrophoresis

  2008cites this paper
• Growth effects of botulinum toxin type A injected into masseter muscle on a developing rat mandible.

  2008cites this paper
• Change of the thickness from skin surface to masseter muscle after botulinum toxin injection into human masseter muscle Directed by Professor

  2008cites this paper
• Spasticity in Spina Bifida

  2008cites this paper
• Botulinum toxin type A in the treatment of patients with cervical dystonia

  2008cites this paper
• Mechanism of action of botulinum neurotoxin and overview of medical countermeasures for intoxication.

  2008cites this paper
• Quality of life of children with cerebral palsy treated with botulinum toxin: are well-being measures appropriate?

  2008cites this paper
• Characterization of some morphological parameters of orbicularis oculi motor neurons in the monkey.

  2008cites this paper
• The timecourse of neurogenic inflammation and the effect of modulatory agents.

  2008influential citation
• Product development tools to enhance drug discovery

  2008cites this paper
• Computer-Assisted Communication Device for Botulinum-Intoxicated Patients

  2008cites this paper
• The emerging role of botulinum toxin in the treatment of temporomandibular disorders.

  2007cites this paper
• CHAPTER 61 – Botulinum neurotoxin

  2007cites this paper
• History and Mechanism of Action

  2007cites this paper
• Botulinum toxin in the management of cerebral palsy

  2007cites this paper
• Use of botulinum toxins in cancer therapy

  2007cites this paper
• Botulinum Toxin in Poststroke Spasticity

  2007cites this paper
• Botulinum toxin type A in refractory chronic migraine: an open-label trial.

  2007cites this paper
• Chemodenervation and Motion Assessment

  2007cites this paper
• Persistence of the synaptosomal‐associated protein‐25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment

  2007cites this paper
• Botulinum toxin treatment for anal fissure.

  2007cites this paper
• Immunochromatographic assay for determination of botulinum neurotoxin type D

  2006cites this paper
• Effect of a supination splint on upper limb function of cerebral palsy children after Botulinum Toxin A

  2006cites this paper
• Botulinum Toxin and Other New Pharmacologic Approaches to Constipation

  2006cites this paper
• Low-Dose Botulinum Toxin with Short-Term Electrical Stimulation in Poststroke Spastic Drop Foot: A Preliminary Study

  2006cites this paper